ASSURE: An Open Label Long-Term Study to Evaluate the Safety and Tolerability of Seladelpar in Subjects with Primary Biliary Cholangitis (PBC)
Clinical Trial Grant
Administered By
Medicine, Gastroenterology
Awarded By
CymaBay Therapeutics
Start Date
June 8, 2021
End Date
June 13, 2024
Administered By
Medicine, Gastroenterology
Awarded By
CymaBay Therapeutics
Start Date
June 8, 2021
End Date
June 13, 2024